American Century Companies
AVXL icon

American Century Companies’s Anavex Life Sciences AVXL Stock Holding History

American Century Companies’s Portfolio AVXL Stock Details AVXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-14,667
Closed -$135K – 2792
2025
Q2 		$135K Buy
+14,667
New +$125K ﹤0.01% 2782
2024
Q4 		– Sell
-55,866
Closed -$317K – 2891
2024
Q3 		$317K Buy
+55,866
New +$322K ﹤0.01% 2624

Other funds holding AVXL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
NL
NWAM LLC Mercer Island, Washington $1.74B AUM 32.48% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

American Century Companies's AVXL Position: Q3 2025 in Review

American Century Companies sold out of Anavex Life Sciences (AVXL) in Q3 2025, closing a stake of 14,667 shares — an estimated $135K sold.

American Century Companies first reported a position in AVXL in Q3 2024 and held it in 2 quarters. The position peaked at $317K in Q3 2024. 186 funds tracked by Wall St. Rank hold AVXL as of Q3 2025.

  • American Century Companies reported no remaining Anavex Life Sciences position as of Q3 2025 after selling out during the quarter.
  • American Century Companies sold 14,667 Anavex Life Sciences shares in Q3 2025, an estimated $135K.
  • American Century Companies first reported a position in Anavex Life Sciences in Q3 2024 and held it in 2 quarters.
  • American Century Companies's Anavex Life Sciences position peaked at $317K in Q3 2024.
  • 186 funds tracked by Wall St. Rank held Anavex Life Sciences as of Q3 2025.

Based on American Century Companies's 13F filing for Q3 2025, filed 12 Nov 2025.